Managed Access Program in Egypt
How the managed access program pathway operates in Egypt.
About Managed Access Program
Manufacturer-operated access programs with structured eligibility and oversight.
How Managed Access Program works in Egypt
Egypt's EDA permits personal-use import of non-registered drugs under physician supervision; process is paperwork-heavy but viable.
Patients in Egypt seeking access under Managed Access Program typically follow this flow: a licensed physician in Egypt issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in Egypt
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.